Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
The ImplantCenter has recently opened the brand-new operating room suited for more complex treatments. This comes alongside numerous additions such as the launch of the four cosy apartments to rest after treatments at the clinic and an implant education facility to expand their services further. These expansions are part of constant improvements that have been occurring for the last 15 years, alongside high quality service.
The area of the clinic has increased by ten-fold to approximately 1800 m2 during the years. Moreover, the oral surgery division was opened in 2015, so eight dental treatment rooms and four oral surgery rooms are now in place today. All of the surgery rooms can serve ambulatory oral surgery treatments. The ImplantCenter is unique in Hungarian private dentistry because they can implement more complex treatments in the framework of one-day oral surgery procedure. This is due to the big and fully equipped operating room opened in November 2017. As part of the service, the ImplantCenter offers one and two-bed private rooms with medical supervision to their patients after each surgery.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8274651-implantcenter-hungarian-dental-service/
FAIR Health has launched a groundbreaking website, YouCanPlanForThis.org, aimed at transforming how people in New York State engage in healthcare planning. A next-generation transparency tool, the free site gives New Yorkers unprecedented access to accurate medical and dental costs and comprehensive educational resources, so they can plan financially for a procedure or episode of care. A national, independent, nonprofit organization dedicated to bringing transparency to healthcare costs and health insurance information, FAIR Health developed YouCanPlanForThis.org by building on its existing, award-winning consumer website and mobile app, with the support of the New York State Health Foundation (NYSHealth).
To view the multimedia release go to:
https://www.multivu.com/players/English/8087151-fair-health-youcanplanforthis-healthcare-planning/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
Pixee Fox, who has undergone many plastic surgeries from eye color implant to breast implant, butt lifting, and 6 ribs removal, travelled to Istanbul last week to be one step closer to her dream of becoming a cartoon character. Pixee shared the results of her Spider Web non surgical Face Lifting procedure, which was developed by Aesthetic Surgeon Bülent Cihantimur M.D.
Dr. Bülent Cihantimur, who listened to and examined Pixee Fox at his Istabul Byomed clinic prior to application, said: “Pixee was in need of a solution for her round face. She said she did not like her U shaped face and was looking for a V shaped contour line. Upon a friend’s recommendation, she went on my website and researched about Spider Web Face Lifting. After making contact, she came to Istanbul to undergo the Spider Web Face Lifting.”
Cihantimur contıunes: “The Spider Web Technique is a non-surgical procedure that shrinks, rejuvenates, and forms the face. In this technique I developed, fine needles are used to net medical threads that can dissolve just like a spider’s web under the skin. The body reacts to these threads and nets its own biological net around them. It boosts collagen production and increases lowered elastin.”
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Abbott announced today the U.S. Food and Drug Administration approval and launch of the iDesign Advanced WaveScan Studio System. The system acts as the "brain" of the LASIK procedure, generating a high-definition scan that measures and maps irregularities of the eye that may impact vision. From these measurements, the iDesign System creates an accurate and personalized LASIK treatment plan based on the unique "blueprint" of each person’s eyes.
The iDesign System captures more than 1,200 micro readings of the eye, as well as identifying the shape of the cornea, its curvature, how light passes through the eye and pupil diameter under different lighting conditions – all in one, three-second scan that can be used to precisely correct vision.
The development of the sensor technology within the iDesign System was the result of an earlier discovery by Abbott scientists, which NASA used to accurately measure and shape the mirrors in the James Webb Space Telescope to ensure it will transmit high resolution images of deep space back to earth. The telescope is scheduled to launch in 2018.
To view the Multimedia News Release, please go to http://www.multivu.com/players/English/7571951-abbott-idesign-system-3-d-eye-map/
Ever wondered what happens behind the doors of one of the world’s most established venues? IFSEC Global.com has got a backstage pass to the Royal Albert Hall to investigate how it keeps world-famous performers, and this iconic building, safe and secure.
Speaking to Amanda Squires, Director of Operations, an insight is given to the co-ordination of the 850 events delivered each year, as well as, the delicate procedure undertaken for getting modern CCTV and access control systems in place in this grade 1 listed building.
Amanda is joining the Protecting London panel debate at IFSEC International 2015, 16 – 18 June at ExCeL London, along with the British Museums’ Health & Safety Manager and Crossrail Ltd.’s Security Manager to discuss the considerations that need to be made when protecting such high value assets.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7537851-protecting-london-royal-albert-hall/
Is there such a thing as a nonsurgical facelift? Aesthetic plastic surgeons are conducting a panel discussion at The Aesthetic Meeting 2015, the annual meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), to determine whether a nonsurgical facelift is a legitimate cosmetic procedure. Surgeons discussed what constitutes a nonsurgical facelift and how it impacts the longitudinal care aesthetic plastic surgeons can provide to address facial aging.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310754-asaps-nonsurgical-facelift/
At 90, Marjorie McFadden found herself unable to swallow. At Stanford Hospital & Clinics, she found innovative care that restored her ability to enjoy food again. Stanford digestive surgeon, Homero Rivas, MD, performed a per oral endoscopic myotomy, or POEM, to correct McFadden's achalasia, an unusual tightening of the muscles at the lower end of the esophagus. For McFadden's full story: http://stanfordhospital.org/newsEvents/newsletters/healthnotes/poem.html
Two beautiful baby girls had their public debut today at The Children’s Hospital of Philadelphia: Allison June and Amelia Lee Tucker, formerly conjoined twins, separated at the Hospital on Nov. 7. The Hospital held a press conference this morning to highlight this new phase in the lives of both infants.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59552-children-s-hospital-of-philadelphia-tucker-conjoined-twins-separated
Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced FDA 510(k) clearance has been granted for the CorPath 200 System to be used in percutaneous coronary interventions (PCI). The technology is now approved in the United States to assist interventional cardiologists in performing PCI, a procedure to restore blood flow to blocked arteries in patients with coronary artery disease (CAD).
“We are pleased to have received clearance from the FDA for the world’s first system designed for robotic-assisted PCI procedures,” said David M. Handler, President and CEO of Corindus Vascular Robotics. “This is an important milestone for interventional cardiology as we take the next step in transforming the way these procedures are performed in the future. The CorPath System offers hospitals the opportunity to bring robotic-assisted technology benefits to their coronary patients and their physicians.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/57343-corindus-vascular-robotics-wins-fda-510k-clearance-for-corpath-200-system
